Today: 9 June 2026
Chevron stock jumps after Q4 beat and Venezuela moves — what investors watch next week
31 January 2026
2 mins read

Chevron stock jumps after Q4 beat and Venezuela moves — what investors watch next week

HOUSTON, Jan 31, 2026, 05:22 (CST) — Market closed.

  • Chevron’s stock ended Friday up 3.3%, settling at $176.90.
  • Chevron exceeded fourth-quarter profit forecasts and highlighted potential to increase Venezuela production, pending U.S. approval.
  • Traders are eyeing Sunday’s OPEC+ meeting alongside Washington’s upcoming moves on Venezuela sanctions.

Chevron shares closed Friday up 3.3% at $176.90, boosted by a quarterly profit beat. Executives also faced tough questions on Venezuela, pushing the stock higher.

Oil also added some momentum. Brent finished 1.3% higher at $70.69 a barrel, while U.S. crude closed at $65.21. Traders were on edge over U.S.-Iran tensions.

U.S. markets are closed for the weekend, leaving crude policy front and center as investors prepare for Monday. OPEC+ plans to meet Sunday, with sources indicating the group will probably maintain its hold on increasing output in March.

Chevron reported adjusted Q4 earnings of $1.52 per share, topping the LSEG forecast of $1.45 but down from $2.06 a year ago. CEO Mike Wirth noted, “We have been a part of Venezuela’s past for more than a century,” as the company explores further opportunities there. Chevron estimates Venezuelan output at roughly 250,000 barrels of oil equivalent per day (boepd) and said it could climb about 50% within 18 to 24 months if the U.S. grants more approvals. The firm also flagged a 185,000 to 225,000 boepd drop in production for Q1 due to maintenance and downtime but maintained a 7% to 10% production growth forecast for 2026, excluding asset sales. Reuters

Wirth said Chevron could handle an extra 100,000 barrels per day of Venezuelan crude at U.S. refineries, beyond the roughly 50,000 bpd currently processed at Pascagoula, Mississippi. He highlighted more heavy-crude capacity at El Segundo, California, but noted it hinges on how Venezuelan barrels compare to other options.

Exxon Mobil took a cautious stance on Venezuela. CEO Darren Woods highlighted technology that might cut costs for extracting the country’s heavy crude but, like Wirth, emphasized the need for firmer legal protections and political stability before making long-term commitments. Still, any easing in Venezuela’s troubles could relieve some pressure in Guyana, where both companies are partners.

Analysts approached the calls anticipating that dynamic. Stephanie Link, chief investment strategist at Hightower Advisors, suggested geopolitics and Venezuela might weigh heavier than the quarter’s headline figures. TD Cowen’s Jason Gabelman noted that better clarity on Venezuela could “create significant upside” for Chevron’s shares. Reuters

Chevron sweetened the deal for shareholders, with the board announcing a 4% hike in the quarterly dividend to $1.78 per share. The payout is set for March 10, to those holding shares by Feb. 17. The company also flagged $1.5 billion in structural cost cuts for 2025, part of a wider plan to trim expenses.

Wirth introduced another growth avenue on Friday, revealing Chevron’s talks with Iraq and Libya about producing fields and new exploration prospects. He emphasized, however, that the company demands competitive returns.

The Venezuela story is double-edged. Gains hinge on U.S. approvals and Caracas delivering steady fiscal policies, and the market won’t hesitate to sell off if politics or sanctions take a sudden turn. On top of that, the company faces an immediate snag: first-quarter production is expected to drop due to scheduled maintenance and bad weather.

The next major event is the OPEC+ decision coming Sunday, Feb. 1, which could jolt crude prices as markets open Monday. Chevron shareholders will also watch for new U.S. actions on Venezuela licensing, alongside the Feb. 17 record date for the boosted dividend.

Stock Market Today

  • IREN Stock Nears $60 on AI Data-Center Expansion, Bitcoin Rebound
    June 9, 2026, 9:55 AM EDT. IREN Limited shares rose 8.9% to $59.19 on Monday, nearing $60 ahead of Tuesday's Nasdaq open amid a bitcoin rebound and a strategic pivot to AI cloud infrastructure. The stock, known for volatility, reflects uncertainty whether it will trade more like a bitcoin miner or an AI cloud operator. IREN plans an 800-megawatt data-center campus in South Australia, supported by clean energy, targeting 2028 energisation and generating substantial jobs. The firm recently secured a $3.4 billion, five-year AI cloud contract with Nvidia and maintains $3.1 billion in annualized run-rate revenue from existing contracts. Despite these developments, risks remain from bitcoin price swings, funding requirements, and data-center construction delays.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
First U.S. bank failure of 2026: What happened after Metropolitan Capital Bank & Trust was shut
Previous Story

First U.S. bank failure of 2026: What happened after Metropolitan Capital Bank & Trust was shut

Gold price set for a bumpy week after historic slide from record highs
Next Story

Gold price set for a bumpy week after historic slide from record highs

Go toTop